CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Vivaer Stylusdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03290300
NCT03290300N/ACompleted

A Prospective, Multi-Center, Non-Randomized Study to Evaluate the Quality of Life Impact After Treatment of Nasal Airway Obstruction Using the Aerin Medical Vivaer Stylus

Aerin Medical·observational·Posted Sep 21, 2017·Updated Feb 15, 2024

In Brief

An observational study evaluating Vivaer Stylus for Nasal Obstruction. Completed, enrolled 39 participants across 8 sites.

Detailed Summary

Evaluation of long-term (5-year) quality of life after nasal airway obstruction treatment with the Aerin Vivaer Stylus

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 21, 2017
Enrollment StartOct 30, 2017
Primary CompletionJul 9, 2022
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 8.8 years ago

Interventions

Vivaer Stylusdevice

Previous nasal obstruction treatment with the Aerin Medical Vivaer Stylus